Follow the money. Inside the Trans Industry Machine
Who really profits when children are diagnosed with gender dysphoria? In this explosive episode, we uncover the billion-dollar transgender medical industry—from puberty blockers and hormone therapies to surgeries and lifelong treatments. Follow the money trail and discover how powerful institutions, pharmaceutical companies, and medical providers are fueling one of the fastest-growing sectors in healthcare. Is this about compassion and care, or about cash and control? Join Jillian Michaels and Chris Moritz as they break down the economics, expose the incentives, and ask the tough questions no one else will.
September 3, 2025
22 min
855
Full
837 of 931
Episode 855 · September 3, 2025
Follow the money. Inside the Trans Industry Machine
0:00 / 22:28
Excerpt playback isn’t available for this episode — use the full-episode link.
Search the Record
Moment search isn’t open for this episode yet
When it opens, you’ll be able to type any phrase and jump straight to the second it was said.
Jillian Michaels Episodes Around September 3, 2025
Episode 837 of 931 — walk the feed in the order it was published.
22:28This episodeFollow the money. Inside the Trans Industry Machine
Summary
Who really profits when children are diagnosed with gender dysphoria? In this explosive episode, we uncover the billion-dollar transgender medical industry—from puberty blockers and hormone therapies to surgeries and lifelong treatments. Follow the money trail and discover how powerful institutions, pharmaceutical companies, and medical providers are fueling one of the fastest-growing sectors in healthcare. Is this about compassion and care, or about cash and control? Join Jillian Michaels and Chris Moritz as they break down the economics, expose the incentives, and ask the tough questions no one else will.
Learn more about your ad choices. Visit megaphone.fm/adchoices
Episode details and artwork are published by the show’s own feed. Sentinel plays short cited excerpts and links every episode back to its publisher.